Skip to main content
. 2022 Sep 21;54(1):2606–2616. doi: 10.1080/07853890.2022.2124449

Figure 6.

Figure 6.

Forest plot of comparison based on histological type. (a) Overall survival of patients receiving ICIs with or without chemotherapy versus patients not receiving ICIs (receiving chemotherapy or placebo only) in squamous NSCLC (male: p = .005, female: p = .400, overall: p = .015). (b) Overall survival of patients receiving ICIs with or without chemotherapy versus patients not receiving ICIs (receiving chemotherapy or placebo only) in non-squamous NSCLC (male: p = .005, female: p = .011, overall: p = .001).